NiQuitin

NiQuitin is a prominent brand of nicotine replacement therapy (NRT) products aimed at helping individuals quit smoking. The brand offers a variety of formats, including transdermal patches, medicated gums, and lozenges, which provide a controlled release of nicotine to alleviate withdrawal symptoms. Originally a flagship product of GSK, the NiQuitin brand was acquired by Perrigo in 2015 as part of a strategic divestment required by regulatory authorities for the European Economic Area. It is particularly well-known for its clinical Step Down patch program, which gradually reduces nicotine dosage over several weeks. Today, NiQuitin remains a key asset in Perrigo's consumer self-care portfolio, marketed extensively across Europe and other international regions. The brand's products are categorized as over-the-counter (OTC) medications and are central to public health efforts in tobacco harm reduction.